CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...
Phase 2
Columbus, Ohio, United States and 158 other locations
and formoterol fumarate metered dose inhaler relative to budesonide metered dose inhaler in adults and adolescents with inadequately controlled asthma...
Phase 3
Columbus, Ohio, United States and 103 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Columbus, Ohio, United States and 318 other locations
the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler in adults and adolescents with inadequately controlled asthma...
Phase 3
Columbus, Ohio, United States and 143 other locations
MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis...
Phase 3
Columbus, Ohio, United States and 92 other locations
inhaler (MDI) containing propellant 1,1-difluoroethane (HFA-152a) or 1,1,1,2-tetrafluoroethane (HFA-134a) in participants aged \>=18 years with asthma...
Phase 3
Dublin, Ohio, United States and 100 other locations
Primary Objective-To evaluate the efficacy of dupilumab compared to omalizumab in reducing the polyp size and improving sense of smellSecondary Objec...
Phase 4
Columbus, Ohio, United States of America and 94 other locations
The primary objective is to assess the safety and tolerability of TAB004 as monotherapy and in combination with toripalimab in subjects with selected...
Phase 1
Columbus, Ohio, United States and 23 other locations
Clinical trials
Research sites
Resources
Legal